Consensus on the management of platinum-sensitive high-grade serous epithelial ovarian cancer in Lebanon-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Consensus on the management of platinum-sensitive high-grade serous epithelial ovarian cancer in Lebanon

Published:2023-06 Issue: Volume:47 Page:101186
ISSN:2352-5789
Container-title:Gynecologic Oncology Reports
language:en
Short-container-title:Gynecologic Oncology Reports

Author:

Abdallah Reem,Atallah David,Bitar Nizar,Chahine Georges,Ghanem Hady,Ghosn Marwan,Kattan Joseph,Nasr Fadi,Makdessi Joseph,Shamseddine Ali

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference67 articles.

1. PARP Inhibitor in Platinum-Resistant Ovarian Cancer: Single-Center Real-World Experience;Agarwal;JCO Glob. Oncol.,2021

2. OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer;Aghajanian;J. Clin. Oncol.,2012

3. Armstrong, D.K., Alvarez, R.D., Bakkum-Gamez, J.N., Barroilhet, L., Behbakht, K., Berchuck, A., et al., 2021. Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Comprehensive Cancer Netw.: JNCCN. 19, 2, 191–226.

4. Baert, T., Ferrero, A., Sehouli, J., O'donnell, D., González-Martín, A., Joly, F., et al., 2021. The systemic treatment of recurrent ovarian cancer revisited. Ann. Oncol., 32, 6, 710–725.

5. First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion;Banerjee;ESMO Open.,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bio-inspired Nanomaterials in Cancer Theranostics;Nanotheranostics for Diagnosis and Therapy;2024

2. Multidisciplinary Surgical Approach to Increase Survival for Advanced Ovarian Cancer in a Tertiary Gynaecological Oncology Centre;Annals of Surgical Oncology;2023-10-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3